Generated by AI
Bluejay Diagnostics Inc. is a medical diagnostics company focused on rapid, near-patient testing solutions for critical care and other clinical settings. Its core Symphony platform combines an analyzer and single-use cartridges to process whole blood and detect key biomarkers, supporting timely assessment of inflammation, infection, and cardiac conditions. The company’s current product development includes the Symphony IL-6 test for monitoring disease progression in critical care, along with additional assays targeting myocardial infarction and congestive heart failure. Bluejay Diagnostics also develops point-of-care diagnostic products designed to give healthcare providers faster, practical insights at the bedside. Headquartered in Acton, Massachusetts, Bluejay Diagnostics Inc. serves the healthcare market through technologies aimed at improving diagnostic workflows and supporting informed clinical decision-making.
Website360 Massachusetts Avenue
Acton, MA, 01720
United States
The latest articles about BJDX.
Summary of Oct 6's posts. Generated by AI.
Summary of Sep 8's posts. Generated by AI.
Summary of Sep 8's posts. Generated by AI.
Investors talking about BJDX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.